Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DYRK1A | Q13627 | 11/20 | 0.56 |
| ▸ | WNT1 | P04628 | 9/20 | 0.56 |
| ▸ | AURKA | O14965 | 3/20 | 0.48 |
| ▸ | AURKB | Q96GD4 | 3/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | PARP1 | P09874 | 1/20 | 0.46 |
| ▸ | NUDT1 | P36639 | 1/20 | 0.44 |
| ▸ | GSK3B | P49841 | 1/20 | 0.43 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.43 |
| ▸ | RHEB | Q15382 | 1/20 | 0.43 |
| ▸ | CLK2 | P49760 | 3/20 | 0.41 |
| ▸ | CLK3 | P49761 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26686261 | 1.00 | DYRK1A (0.56) | DYRK1AWNT1AURKAAURKBKDM4E | |
| SCHEMBL31240454 | 0.87 | DYRK1A (0.54) | DYRK1AWNT1PARP1CLK2CLK3 | |
| SCHEMBL26685908 | 0.87 | NUDT1 (0.49) | DYRK1AWNT1NUDT1CLK2CLK3 | |
| SCHEMBL31240736 | 0.87 | NUDT1 (0.49) | DYRK1AWNT1NUDT1CLK2CLK3 | |
| SCHEMBL26686398 | 0.85 | AURKA (0.44) | DYRK1AWNT1AURKAAURKBKDM4E | |
| SCHEMBL30633364 | 0.85 | AURKA (0.44) | DYRK1AWNT1AURKAAURKBKDM4E | |
| SCHEMBL31240633 | 0.84 | CCNK (0.54) | DYRK1AWNT1KDM4ENUDT1CLK2 | |
| SCHEMBL26686484 | 0.84 | CCNK (0.54) | DYRK1AWNT1KDM4ENUDT1CLK2 | |
| SCHEMBL30633128 | 0.83 | CCNK (0.55) | DYRK1AWNT1NUDT1 | |
| SCHEMBL30633338 | 0.83 | NUDT1 (0.48) | DYRK1AWNT1NUDT1GSK3BCLK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4705291-A1 | IKK-ALPHA INHIBITORS | Cancer Research Technology Limited (GB) | 2026-03-11 | — | — | EP | claimed |
| CN-119562945-A | IKK inhibitors | 癌症研究技术有限公司 | 2025-03-04 | — | — | CN | claimed |
| WO-2024228035-A1 | IKK-ALPHA INHIBITORS | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2024-11-07 | — | — | WO | claimed |
| EP-4705291-A1 | IKK-ALPHA INHIBITORS | Cancer Research Technology Limited (GB) | 2026-03-11 | — | — | EP | disclosed |
| EP-4522597-A1 | IKK INHIBITORS | Cancer Research Technology Limited (GB) | 2025-03-19 | — | — | EP | disclosed |
| CN-119562945-A | IKK inhibitors | 癌症研究技术有限公司 | 2025-03-04 | — | — | CN | disclosed |
| WO-2024228035-A1 | IKK-ALPHA INHIBITORS | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2024-11-07 | — | — | WO | disclosed |
| WO-2023218201-A1 | IKK INHIBITORS | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2023-11-16 | — | — | WO | disclosed |